Concepedia

C. Farley

CF

11

Publications

771

Citations

10

H-Index

2007

Active since

Affiliations

Sarah Cannon(Current)

Tennessee Oncology

Sarah Cannon Research Institute

C. Farley is an author at Sarah Cannon specializing in cancer therapeutics, oncology, and medicine.

Top concepts

Publications per year

2007–2010

11

Publications

11

Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab

David R. Spigel, John D. Hainsworth, Denise A. Yardley et al. · Journal of Clinical Oncology · 2009 · 296 citations

, , +17

Phase II Trial of Bevacizumab and Erlotinib in Carcinomas of Unknown Primary Site: The Minnie Pearl Cancer Research Network

John D. Hainsworth, David R. Spigel, C. Farley et al. · Journal of Clinical Oncology · 2007 · 113 citations · Full text

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

David R. Spigel, F. Anthony Greco, John D. Zubkus et al. · Journal of Thoracic Oncology · 2009 · 85 citations · Full text

, , +5

Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial

John D. Hainsworth, David R. Spigel, Jeffrey A. Sosman et al. · Clinical Genitourinary Cancer · 2007 · 79 citations

, , +7

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer

John D. Hainsworth, David R. Spigel, C. Farley et al. · Cancer · 2007 · 70 citations

Rows per page

1–5 of 11